Pathlab receives various enquiries and proposals from interested parties from time to time, CEO Marcus Kam said. Pathology & Clinical Laboratory, a medical testing company, is considering selling its ...
Over the last 5 years, the share price of Star Imaging and Path Lab has declined 15.94% CAGR. Over the past year, the corresponding return has been -58.04%. Star Imaging and Path Lab’s current P/E of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results